Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY, FIMM | Sorafenib |
CTRPv2 | sorafenib |
PharmacoGx | Sorafenib |
Database | Identifier |
---|---|
Smiles: | CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F |
Inchikey: | MLDQJTXFUGDVEO-UHFFFAOYSA-N |
Pubchem: | 216239 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HLA-DPB1 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.01 |
mRNA | GLRA3 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | PUS7L | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
mRNA | NKX6-1 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | PLPPR2 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
mRNA | LFNG | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
mRNA | NUDT3 | FIMM | pan-cancer | AAC | 0.42 | 0.01 |
mRNA | IREB2 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | SURF2 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | ZNF518B | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |